dr. Turkan Terkivatan

Medicine and Dentistry

1. Kidney Transplantation 100%
2. Surgery 64%
3. Liver Surgery 55%
4. Hepatectomy 52%
5. Hepatocellular Adenoma 51%
6. Surgeon 40%
7. Nephrectomy 40%
8. Liver Tumor 39%
9. Operation Duration 34%
10. Graft Survival 33%
11. Enhanced Recovery After Surgery 33%
12. Bleeding 31%
13. Neoplasm 30%
14. Percutaneous Nephrostomy 26%
15. Ureteroneocystostomy 25%
16. Cohort Analysis 24%
17. Odds Ratio 23%
18. Learning Curve 20%
19. Kidney Function 19%
20. Randomized Controlled Trial 19%
21. Liver Adenoma 19%
22. Transplantation 18%
23. Urinary System 18%
24. Multivariate Analysis 18%
25. Decision Making 17%
26. Balloon Dilatation 16%
27. Randomized Clinical Trial 16%
28. Stenting 16%
29. Meta-Analysis 16%
30. Hepatocellular Carcinoma 16%
31. Systematic Review 16%
32. Ex Vivo 16%
33. Liver Transplantation 16%
34. Methylmalonic Acidemia 16%
35. Glomerular Filtration Rate 16%
36. Villous Adenoma 16%
37. Cytotoxic T-Cell 16%
38. Sulforaphane 16%
39. Dietary Intake 16%
40. Case-Control Study 16%
41. Low Drug Dose 16%
42. Ureter Stricture 16%
43. Adenocarcinoma 16%
44. Surgical Approach 16%
45. Abdominal Bleeding 16%
46. Coagulopathy 16%
47. Body Mass Index 16%
48. Postoperative Complication 14%
49. Kidney Graft 14%
50. Acetylsalicylic Acid 13%